Sort
35,931 grants matching “parkinsons”
Biomarkers for early intervention in Parkinson disease
$506,654Clemens R Scherzer · Brigham And Women'S Hospital · U01 · FY2016 · NS
Biomarkers for early intervention in Parkinson disease
$506,654Clemens R Scherzer · Brigham And Women'S Hospital · U01 · FY2015 · NS
Development and application of a pipeline to identify tandem repeat expansions as a cause of Parkinson's disease in the AMP PD cohort
$506,627Andrew James Sharp · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · NS
Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease
$506,507Paul T Kotzbauer · Washington University · R01 · FY2020 · NS
Cortical Alpha-Synuclein in Dementia
$506,456Georgina Aldridge · University Of Iowa · R01 · FY2025 · NS
Biomarkers for early intervention in Parkinson disease
$506,440Clemens R Scherzer · Brigham And Women'S Hospital · U01 · FY2013 · NS
Integrative NMR and biophysical studies of fibrillar protein assemblies in health and disease
$506,439Jean S Baum · Rutgers, The State Univ Of N.J. · R35 · FY2020 · GM
GENE-METAL INTERACTIONS AND PARKINSON'S DISEASE
$506,245Howard Hu · Brigham And Women'S Hospital · R01 · FY2006 · ES
CORE--CLININCAL
$506,220Donna L. Masterman · University Of California Los Angeles · P50 · FY2007 · AG
Proteolytic and chaperone machines implicated in virulence and disease
$506,140Robert T Sauer · Massachusetts Institute Of Technology · R01 · FY2015 · AI
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
$506,098Justin S. Hanes · Johns Hopkins University · R01 · FY2018 · CA
In vitro myelination assay modeling the environment of MS lesions for predictive discovery of remyelinating therapies.
$506,083Anna Jagielska · Artificial Axon Labs Inc. · R43 · FY2024 · NS
Mechanistic Investigation of Neuropathological Interactions between COVID-19 and Progression of Lewy Pathology and Dementia
$506,052Xiaohong Lu · Louisiana State Univ Hsc Shreveport · R56 · FY2024 · NS
Mechanisms of synaptic dysfunction in Parkinson's and other synuclein-linked diseases
$505,993Jennifer R Morgan · Marine Biological Laboratory · R01 · FY2018 · NS
Developmental Effects of Manganese Exposure in Rural Adolescents: The CARES Cohort Comes of Age
$505,975Erin N Haynes · University Of Kentucky · R01 · FY2020 · ES
Co-Regulation of Striatal Dopamine and Acetylcholine During Flexible Learning
$505,871Christoph Kellendonk · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2023 · MH
Patient Specific Parameter Optimization of Thalamic Stimulation for Treatment of Epilepsy
$505,835Robert A McGovern · University Of Minnesota · U01 · FY2024 · NS
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression
$505,592Thomas Tuschl · Rockefeller University · R01 · FY2021 · AI
Spinocerebellar Ataxia Type 2 Gene and Gene Product
$505,585Stefan M. Pulst · University Of Utah · R37 · FY2014 · NS
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
$505,575Benzi M Kluger · University Of Colorado Denver · R01 · FY2017 · NR
Functional amyloid formation in streptococcus mutans
$505,530L. Jeannine Brady · University Of Florida · R56 · FY2024 · DE
PDZ Domains and AMPA Receptor Function
$505,524Richard L Huganir · Johns Hopkins University · R01 · FY2016 · NS
Augmented Preclinical Alzheimer's Disease Detection Through Wearable Health and Driving Behavior Data.
$505,516Jon Andrew Corkey · Amissa, Inc. · R43 · FY2024 · AG
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases
$505,452Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2021 · AG
Core--Ascertainment and Clinical
$505,389William K. Scott · Duke University · P50 · FY2006 · NS